While Kronos Worldwide, Inc. (NYSE:KRO) might not have the largest market cap around , it saw a decent share price growth of 17% on the NYSE over the last few months. Shareholders may appreciate the ...
Deals were signed on Monday for the commercial development of the Kronos gas reservoir located within offshore Block 6 of Cyprus’ Exclusive Economic Zone. The agreements were inked on the sidelines of ...
CAMBRIDGE, England, October 06, 2025--(BUSINESS WIRE)--Ignota Labs, the AI drug turnaround company, has announced its acquisition of Kronos’s clinical assets, istisociclib, a CDK9 inhibitor, and ...
NANO Nuclear Energy Inc. (NASDAQ: NNE) announced its third fiscal quarter results, revealing significant milestones in the development of its KRONOS Micro Modular Reactor (MMR). The company advanced U ...
Kronos Quartet are marking the 80th anniversary of the first nuclear detonation by covering Bob Dylan‘s “A Hard Rain’s A-Gonna Fall” with the Hard Rain Collective. Proceeds benefit the Red Hot ...
Today (July 16) marks the 80th anniversary of the Trinity test, during which a team of U.S. scientists led by J. Robert Oppenheimer detonated the world’s first atomic bomb in the deserts of New Mexico ...
With the walls quickly closing in, Kronos Bio has accepted a buyout from notorious biotech acquirer Concentra Biosciences. Tang Capital Partners’ Concentra inked a definitive deal to acquire Kronos’ ...
(RTTNews) - Kronos Bio (KRON) has entered into a definitive merger agreement with Concentra Biosciences, LLC, whereby Concentra will acquire Kronos Bio for $0.57 in cash per share of Kronos Bio common ...
Performances in N.Y.C. Advertisement Supported by The venerable quartet returned to Zankel Hall with a typically eclectic program and a newfound emotional intensity. By Corinna da Fonseca-Wollheim The ...
Antonia Haynes is a Game Rant writer who resides in a small seaside town in England where she has lived her whole life. Beginning her video game writing career in 2014, and having an avid love of ...
Kronos Bio, a San Mateo biotech company, is losing millions of dollars a month and recently had to discontinue its sole clinical-stage compound because of adverse side effects. Now, the company is ...
Kronos Q324 sales volumes soared, offsetting flat TiO2 selling prices to deliver +22% YoY revenue growth along with improved profitability. The company faces high growth expectations as it integrates ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback